Continuing significant increase in young adults with gonorrhoea The number of people in the Netherlands with gonorrhoea is continuing to increase significantly. Diagnosed cases of this sexually transmitted infection increased by 31% in 2023, compared to 2022. These cases involved people who were tested at a sexual health centre operated by the Municipal Public Health Services (GGDs).
Increase in STI consultations in 2023, rise in gonorrhoea cases persists The number of consultations for sexually transmitted infections (STIs) at Sexual Health Centres (SHCs) was higher in the first half of 2023 compared to the previous year. Notably, the number of gonorrhoea cases continues to rise.
More STIs diagnosed in 2022, most significant increase in gonorrhoea More people got tested for an STI at Sexual Health Centres (SHCs) in 2022 than in 2021. There were a total of 164,715 consultations at SHCs. The percentage of people found to have an STI (21%) was also higher than in 2021.
Municipal Public Health Services once again conduct more STI consultations than before COVID-19 The number of STI consultations at the Sexual Health Centres of the Municipal Public Health Services (GGDs) was 19% higher in 2022 compared to 2021.
Higher alert level for Ebola There is an Ebola outbreak in several regions of Uganda that are also frequented by tourists. RIVM therefore asks medical professionals to be alert to symptoms that could indicate Ebola among people who have travelled to Uganda, and to request diagnostics to rule out or confirm Ebola.
Number of STI tests at sexual health centres are rising again In 2021, more than 138,000 people were tested for sexually transmitted infections (STIs) at a centre for sexual health.
More STI tests conducted by Sexual Health Centres In 2021, more people visited a Sexual Health Centre (SHC) to get tested for sexually transmitted infections (STIs) than in 2020. This figure is still lower than in 2019, the year before the coronavirus outbreak.
New WHO Collaborating Centre hosted by RIVM combines laboratory preparedness and biorisk RIVM has been designated WHO Collaborating Centre for Laboratory Preparedness and Response for High Threat Pathogens and Biorisk by the World Health Organization (WHO).
Breast cancer screening resumes on Bonaire after COVID-19 hiatus Women aged 50 to 75 years on Bonaire can participate in the breast cancer screening programme again as of Wednesday, May 26, 2021. This was temporarily halted in 2020 due to the COVID-19 pandemic.
New WHO protocol for integrated One Health surveillance of antibiotic resistance: the Tricycle protocol The World Health Organization (WHO) has developed a protocol for global One Health surveillance of antimicrobial resistance based on one indicator, Extended Spectrum Beta-Lactamase producing E. WHO